Typicality: | 0.437 |
Saliency: | 0.058 |
before enrolling in this study | 4 | temporal |
survivor → completed → cancer treatment | 4 |
negative | neutral | positive |
0.023 | 0.651 | 0.327 |
Raw frequency | 4 |
Normalized frequency | 0.058 |
Modifier score | 1.000 |
Perplexity | 240.563 |